| Pharmaceutical active ingredients: |
| LoratadinePseudoephedrine Sulfate |
| Available forms, composition and doses of Nularef-D: |
| N / A |
| Nularef-D medical category: |
| Human:Alpha- and beta-adrenergic agonistsAntihistamines and antiallergicsAntihistamines second generationCough and cold preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA52 - Pseudoephedrine, combinationsR06AX13 - Loratadine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Lafedar Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Loratadine; Pseudoephedrine | Loratadine; Pseudoephedrine Sulfate | Ranbaxy |
| Narine | Loratadine; Pseudoephedrine Sulfate | Schering-Plough |
| Nastizol-L | Loratadine; Pseudoephedrine Sulfate | Bago Laboratorios |
| Novo Vagran D | Loratadine; Pseudoephedrine Sulfate | Finadiet |
| Novo-Nastizol | Loratadine; Pseudoephedrine Sulfate | Bago Laboratorios |
| Polaratyne D | Loratadine; Pseudoephedrine Sulfate | Schering-Plough |
| Rinase | Loratadine; Pseudoephedrine Sulfate | Schering-Plough |
| Rinomex | Loratadine; Pseudoephedrine Sulfate | Recalcine Laboratorios |
| Roletra-D | Loratadine; Pseudoephedrine Sulfate | Ranbaxy |
| Sensibit D | Loratadine; Pseudoephedrine Sulfate | Liomont Laboratorios |